20MAY2026, Picture Source: https://www.fertilitycounts.com/the-fertility-challenge-in-asia-pacific/ Recent developments in Malaysia and across the wider Asia-Pacific region suggest that fertility treatment is gradually shifting from being viewed as a private healthcare service toward becoming part of broader demographic and economic policy planning. The recent Selangor initiative highlighted by… Read More »APAC’s fertility future becoming a public policy priority

Egg donation IVF is one of the most effective fertility treatments available today but also one of the most complex when it comes to pricing. Across the world, the cost of donor egg IVF vary dramatically from a few thousand euros to well over €55,000… Read More »Donor Egg treatment costs worldwide

Germany has traditionally been seen as a country with strong healthcare coverage. But when it comes to fertility treatment, the reality is far more complex and increasingly, insufficient for modern family-building needs. A new movement of employer-sponsored fertility insurance is now entering the German market,… Read More »Fertility insurance in Germany: Why the need exist and why employers are supporting it?

Debate is on-going at present in the Danish media as to growing demand for social egg freezing, implications and possible concerns as illustrated by an article (in Danish): https://lnkd.in/eJzDsXJQ – we have made a summary in English below as well as more comments following as… Read More »Social egg freezing (oocyte freezing for non-medical reasons) in Denmark

The key point is that the old regime was mainly based on the EU Tissue and Cells Directive (2004/23/EC) and related implementing acts, whereas the new regime is the SoHO Regulation, Regulation (EU) 2024/1938. Unlike a directive, a regulation applies much more uniformly across Member… Read More »Comparison of the existing EU Tissue and Cells Directive framework vs. the new EU SoHO Regulation, specifically for egg and sperm donation.

Demand for fertility care has never been higher. Rising maternal age, changing family structures, and increased awareness of reproductive medicine are driving growth in the global fertility market. Yet despite this demand, access to fertility treatment remains limited for millions of people worldwide. In many… Read More »Why millions of people have no access to fertility treatment – the challenges?

Summary of Key Recommendations 1. Establish an International (EU-wide) offspring limitESHRE supports setting an international limit on the number of families created per donor to reduce uncertainty, overwhelm, and feelings of commodification among donor-conceived people and donors. Because a worldwide treaty is unrealistic, ESHRE recommends… Read More »International limits on the number of offspring per gamete donor (ESHRE stakeholder review version)

Background:The EU’s SoHO Regulation (2024/1938), which entered into force on 6 August 2024, will apply fully from 7 August 2027. This Regulation establishes a uniform legal framework across the EU/EEA for the quality, safety, and traceability of Substances of Human Origin (SoHO) — including sperm,… Read More »EU SoHO regulation – key compliance requirements & impact on fertility treatments and donor gametes (by ESHRE)

Main Recommendation:The four Nordic National Ethics Councils (Sweden, Denmark, Finland, Norway) jointly call for an international limit on the number of children that can be conceived from a single egg or sperm donor. They urge the Nordic countries to initiate EU and Council of Europe-level… Read More »The Nordic Ethics Councils are calling for international limits on how many children can be conceived from a single sperm or egg donor.

In recent years, the European Union has undertaken significant reforms to enhance the safety and quality of substances of human origin (SoHO), which encompass blood, tissues, cells, and other human-derived materials used in medical treatments. These reforms aim to modernize the regulatory framework, ensuring it… Read More »Council adopts new rules on substances of human origin